Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genomics Laboratory, |
RCV005251520 | SCV005902209 | pathogenic | CTNNB1-related disorder | 2024-12-16 | criteria provided, single submitter | clinical testing | A CTNNB1 c.999_1006delinsT (p.Glu334Tyrfs*9) variant was identified at an allelic fraction consistent with somatic origin. To our knowledge, this variant has not been reported in the medical literature. It is absent from the general population (gnomAD v.4.1.0), indicating it is not a common variant. This variant causes a frameshift by deleting seven nucleotides followed by a single nucleotide variant, leading to a premature termination codon, which is predicted to lead to nonsense mediated decay. Based on available information and an internally developed protocol informed by the ACMG/AMP guidelines for variant interpretation and gene-specific practices from the ClinGen Criteria Specification Registry (Leon-Quintero FZ et al., PMID: 39434542), the CTNNB1 c.999_1006delinsT (p.Glu334Tyrfs*9) variant is pathogenic. |